Provided by Tiger Trade Technology Pte. Ltd.

vTv Therapeutics

33.63
+1.685.26%
Volume:26.82K
Turnover:885.68K
Market Cap:132.43M
PE:-31.85
High:34.00
Open:32.55
Low:32.15
Close:31.95
52wk High:44.00
52wk Low:17.00
Shares:3.94M
Float Shares:2.42M
Volume Ratio:0.47
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0558
EPS(LYR):-3.2022
ROE:-15.80%
ROA:-10.14%
PB:6.21
PE(LYR):-10.50

Loading ...

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 03

vTv Therapeutics Shareholders Approve Directors, Question Executive Pay

TIPRANKS
·
Jun 30

Vtv Therapeutics Holds Annual Shareholder Meeting

Reuters
·
Jun 30

vTv Therapeutics grants 2,500 inducement stock options at $34.3 per share

Reuters
·
Jun 03

vTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 03

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 03

H.C. Wainwright Sticks to Their Buy Rating for vTv Therapeutics (VTVT)

TIPRANKS
·
May 27

vTv Therapeutics: Buy Rating Reiterated on Favorable Risk-Reward and Clinical Momentum; $67 Price Target Unchanged

TIPRANKS
·
May 15

Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT), Waters (WAT) and Alpha Teknova (TKNO)

TIPRANKS
·
May 14

Analyst Maintains Buy on vTv Therapeutics, Reiterates Unchanged $49 Price Target Amid Progress of Cadisegliatin Program

TIPRANKS
·
May 14

vTv Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $45 From $47

THOMSON REUTERS
·
May 14

Analysts Offer Insights on Healthcare Companies: Damora Therapeutics (DMRA) and vTv Therapeutics (VTVT)

TIPRANKS
·
May 14

vTv Therapeutics Expands At-The-Market Share Program Capacity

TIPRANKS
·
May 14

vTv Therapeutics Inc - Increases Class a Common Stock Offered Under Atm Program to Full Amount - SEC Filing

THOMSON REUTERS
·
May 14

vTv Therapeutics boosts share capacity under at-the-market equity sales program

Reuters
·
May 14

vTv Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

vTv Therapeutics Q1 EPS $1.65 Beats $(0.10) Estimate, Sales $36.839M Beat $20.000M Estimate

Benzinga Earnings
·
May 14

vTv Therapeutics reports Q1 EPS $1.65, consensus 21c

TIPRANKS
·
May 14

vTv Therapeutics posts Q1 profit on license payment

Reuters
·
May 14

vTv Therapeutics Q1 FY26 swings to net income of $24.13 million; revenue $36.84 million

Reuters
·
May 14